Age- and stage-specific competing mortality after colorectal cancer resection
Abstract Mortality after colorectal cancer (CRC) resection reflects both cancer progression and competing health risks, but their balance may change with age, stage and time already survived. We identified 175,184 patients with stage I-III colorectal adenocarcinoma diagnosed during 2004–2018 who underwent cancer-directed resection in the Surveillance, Epidemiology, and End Results Program. Stage- and age-specific cumulative-incidence functions, Fine-Gray models and landmark analyses were used to compare CRC-specific and other-cause death. In stage I, other-cause mortality became predominant within 1–3 months in all age groups. In stage II, no crossover occurred within 10 years among patients aged < 65 years, whereas stable crossovers occurred between 2.5 and 7.3 years in older groups. No stage III age group crossed within 10 years. Age-by-stage interactions were significant for both outcomes (P < 0.001). Among 5-year survivors, subsequent 5-year CRC-death incidences were 4.3%, 8.6% and 13.1% in stages I-III, whereas corresponding other-cause incidences were 16.4%, 18.4% and 12.1%. Mortality composition after CRC resection is jointly associated with age, stage and survival time, supporting individualized prognostic communication, geriatric assessment and survivorship planning.
Authors
- Daqing Sun
- Fangxu Yin (ORCID: https://orcid.org/0000-0002-8211-5420)
- Guoshuai Xu (ORCID: https://orcid.org/0009-0000-8483-0850)
- Bingbing Ren (ORCID: https://orcid.org/0000-0002-9359-9846)
- Nan Yao
- Xiaohui Dou
- Mingyu Zheng
- Wenyue Ma
- Yaqian Ping
- Wei Sun
- Wenqiang Li
Institutions
- Tianjin Medical University General Hospital (CN)
- Yuhuangding Hospital (CN)
- Aerospace Center Hospital (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1038/s41598-026-79978-x
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Tianjin Medical University
- National Cancer Institute